A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease
Crossref DOI link: https://doi.org/10.1007/s10549-014-2939-1
Published Online: 2014-04-13
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Coleman, Robert
Aksnes, Anne-Kirsti
Naume, Bjørn
Garcia, Camilo
Jerusalem, Guy
Piccart, Martine
Vobecky, Nancy
Thuresson, Marcus
Flamen, Patrick
License valid from 2014-04-13